Sign Up And Receive Our Latest Promotions!
.svg){kind=small}
Our latest
Press Releases & Updates
Latest press releases
EssilorLuxottica acquires RetinAI, accelerating transformative AI and data-powered eye health solutions
RetinAI and FVS Announce CE-MDR Certification for Co-developed AI-based Diabetic Retinopathy Screening Algorithm, LuxIA®
Ikerian Announces Series B Funding First close of USD 8M Led by Sanoptis with Commercial Agreement to Expand RetinAI Discovery in Europe
RetinAI Partners with MAXO to Advance Clinical Studies in Dry Eye Disease
Latest updates
RetinAI on the Top100 Swiss Startups [SEPTEMBER’18]
This year RetinAI has been selected as one of the TOP 100 of Swiss Startups 2018! It’s a great recognition for the team. We are proud of the results we are achieving and we are extremely excited about the future ahead!
Welcome to the new RetinAI [SEPTEMBER'18]
There's nothing permanent except change - Heraclitus. We are incredibly pleased to announce our new logo at RetinAI! This new image reflects our values, strengths and willingness to connect the anatomical and digital worlds to provide a better healthcare for the patient.
Venture Leaders China 2018 [SEPTEMBER'18]
The 10-day business roadshow in China with VentureLab is only a week away! Get to know the Venture Leaders China team member Carlos Ciller, CEO & co-founder of RetinAI before the trip begins! Source: VentureLab.
AGEFI - RetinAI [JULY'18]
RetinAI is honoured to appear in the first page of AGEFI this 5th of July! Another opportunity to highlight how advanced machine learning and artificial intelligence are changing the world of ophthalmic care for the benefit of the patient and healthcare systems worldwide.
Contact us for more informations! We are happy to hear from you!
Ikerian AG (HQ)
Freiburgstrasse 3
3010 Bern
Switzerland
RetinAI US Inc. (US)
6 Liberty Square
#2498 Boston, MA 02109
United States
Imprint/Legal Notice | Data Processing Agreement | Privacy Notice | Created by Ikerian AG. All rights reserved 2016-2025 ©